Avastin increases tumor response rates in breast cancer patients before surgery

[News]

Amid the controversy surrounding the Food and Drug Administration's ruling that Avastin should no longer be used to treat metastatic breast cancer, a new multinational Phase III clinical trial shows that Avastin significantly increased tumor response rates in breast cancer patients when given before surgery.

More... (http://www.news-medical.net/news/20110824/Avastin-increases-tumor-response-rates-in-breast-cancer-patients-before-surgery.aspx)